---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "RpY8rpJ1ovai8B9aF8y2GBRrUkTC0RhOs+OLZ7TLudep68JfqMS/E3zxqvhZAtkE+CygvfJpHkVwc/f0f7VO5vGEab+t+K0vlky0QFj1g1iT1YEFGSVMEhKwj64kgXg+IlwrDdWxVgwKuX1pl7AJ6W20la7ZJe2hLv4yZtJlqPOByJCQbi2oWCBTdE7c8oRAN/la+Gp6KpzDRpUOcgPCpAl+B4Ivs3Y5hwDjjjQp7Fqr4Ry9xcv6+HI2br2YLiCTqx/XAff5mXwUBrNDYkZZDx91WXlV83s8WlTMIVQr0KAf5FYDSsOxOZsq1jgFUGO8Mr9Y16eWsO6xkbX6Qrmv7xgRLcviBG98/a3ZY+X7ZGw=;iXOhc1ZcEV89i7LSx0kyaw=="
---

